TREA

90218072 - CIPLA THERAPEUTICS

Follow

Information

  • Trademark
  • 90218072
  • Serial Number
    90218072
  • Filing Date
    September 28, 2020
    3 years ago
  • Transaction Date
    April 27, 2024
    2 months ago
  • Status Date
    April 15, 2024
    2 months ago
  • Published for Opposition Date
    August 24, 2021
    2 years ago
  • Location Date
    October 19, 2021
    2 years ago
  • Status Code
    734
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    FRENCH, CURTIS W
  • Attorney Docket Number
    CIPLA.094TFC
    Attorney Name
    Stacey Halpern
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
3
Mark Identification
CIPLA THERAPEUTICS
Case File Statements
  • DM0000: The mark consists of the word "CIPLA" in stylized blue font positioned above the word "THERAPEUTICS" in stylized turquoise font with the image of the a semi-circle composed of three separate semi-circles, in blue and turquoise, which is positioned to the left of the wording. White is used for the background but is not claimed as a feature of the mark.
  • GS0051: Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of gastro-intestinal disorders, disorders of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, seizures Huntington's disease, multiple sclerosis; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, namely, Coronary artery disease, Heart attack, abnormal heart rhythms, arrhythmias, heart failure, heart valve disease, congenital heart disease, cardiomyopathy, pericardial disease; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of migraines and other forms of headache, namely, sinus headaches, tension headaches, cluster headaches and rebound headaches; pharmaceutical and medicinal preparations, namely, analgesics; pharmaceutical and medicinal preparations, namely, antiviral and anti-retroviral pharmaceutical preparations for the treatment of viral brain diseases; pharmaceutical and medicinal preparations, namely, anti-infectives; pharmaceutical and medicinal preparations, namely, anti-inflammatories; pharmaceutical and medicinal preparations, namely, antibiotics; pharmaceutical and medicinal preparations, namely, antidepressants; pharmaceutical and medicinal preparations, namely, anti-cancer preparations; pharmaceutical and medicinal preparations, namely, medicated soaps and lotions for the skin and hair, namely, medicated acne lotion, medicated body moisturizing lotion, medicated lotion for eczema and seborrheic dermatitis, medicated hair shampoo and hair scalp lotion, medicated anti-dandruff lotion; pharmaceutical and medicinal preparations, namely, decongestants and antihistamines; pharmaceutical and medicinal preparations, namely, scabicides; pharmaceutical and medicinal preparations, namely, anti-malarials; pharmaceutical and medicinal preparations, namely, cough suppressants; pharmaceutical and medicinal preparations, namely, cough and cold preparations; pharmaceutical and medicinal preparations, namely, expectorants; pharmaceutical and medicinal preparations, namely, anti-leukemic agents; pharmaceutical and medicinal preparations, namely, tissue sealants; pharmaceutical and medicinal preparations, namely, vasopressors; pharmaceutical and medicinal preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; pharmaceutical and medicinal preparations, namely, preparations for the treatment of gout; pharmaceutical and medicinal preparations, namely, preparations for cessation of smoking; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of genitourinary diseases and disorders, namely, urological diseases, urological disorders, urinary incontinence, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of pain from burns, hemolytic diseases and disorders, neuropathic pain; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of fibromyalgia, post-herpetic neuralgia, chronic pain, obesity, inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), viral diseases and disorders, namely, herpes, hepatitis, substance abuse disorders, namely, alcoholism and drug addiction, carpel tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, yeast infections, prostate disorders, pulmonary disorders, sleep disorders, namely, insomnia and, restless leg syndrome, premature ejaculation, macular degeneration, thrombosis and thromboembolism; pharmaceutical and medicinal preparations, namely, vaccines for human use; pharmaceutical and medicinal preparations, namely, adjuvants for use with human vaccines; pharmaceutical and medicinal preparations in the nature of veterinary preparations, namely, flea and tick preparations, vaccines, anti inflammatories, mastitis preparations, and oncological preparations
  • CC0000: The color(s) blue and turquoise is/are claimed as a feature of the mark.
  • GS0441: Medical care services; medical treatment services for the treatment, alleviation and prevention of gastro-intestinal disorders, disorders of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, seizures Huntington's disease, multiple sclerosis, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, namely, coronary artery disease, heart attack, abnormal heart rhythms, arrhythmias, heart failure, heart valve disease, congenital heart disease, cardiomyopathy, pericardial disease, migraines and other forms of headache, namely, sinus headaches, tension headaches, cluster headaches and rebound headaches, genitourinary diseases and disorders, namely, urological diseases, urological disorders, urinary incontinence, infertility, sexually transmitted diseases, inflammatory pelvic diseases; and medical treatment services for treatment, alleviation and prevention of pain from burns, hemolytic diseases and disorders, neuropathic pain; fibromyalgia, post-herpetic neuralgia, chronic pain, obesity, inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), viral diseases and disorders, namely, herpes, hepatitis, substance abuse disorders, namely, alcoholism and drug addiction, carpel tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, yeast infections, prostate disorders, pulmonary disorders, sleep disorders, namely, insomnia and, restless leg syndrome, premature ejaculation, macular degeneration, thrombosis and thromboembolism
  • DS0000: "THERAPEUTICS"
Case File Event Statements
  • 10/1/2020 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 11/10/2020 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/11/2020 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 2/18/2021 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/22/2021 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/22/2021 - 3 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/22/2021 - 3 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/9/2021 - 2 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/9/2021 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/9/2021 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/16/2021 - 2 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/4/2021 - 2 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/24/2021 - 2 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/24/2021 - 2 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/19/2021 - 2 years ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/19/2022 - 2 years ago
    27 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/23/2022 - 2 years ago
    16 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 5/23/2022 - 2 years ago
    17 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 5/31/2022 - 2 years ago
    18 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/31/2022 - 2 years ago
    19 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/31/2022 - 2 years ago
    20 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 5/31/2022 - 2 years ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/31/2022 - 2 years ago
    22 - TEAS PETITION TO REVIVE RECEIVED Type: PROA
  • 5/31/2022 - 2 years ago
    23 - PETITION TO REVIVE-GRANTED Type: PETG
  • 5/31/2022 - 2 years ago
    24 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX
  • 6/1/2022 - 2 years ago
    25 - NOTICE OF REVIVAL - E-MAILED Type: NREV
  • 7/11/2022 - a year ago
    26 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/13/2022 - a year ago
    28 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/14/2022 - a year ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/18/2022 - a year ago
    30 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/18/2022 - a year ago
    31 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/18/2022 - a year ago
    32 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/21/2022 - a year ago
    33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/13/2023 - a year ago
    34 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/13/2023 - a year ago
    35 - SOU EXTENSION 3 FILED Type: EXT3
  • 4/13/2023 - a year ago
    36 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 4/15/2023 - a year ago
    37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/12/2023 - 8 months ago
    38 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/12/2023 - 8 months ago
    39 - SOU EXTENSION 4 FILED Type: EXT4
  • 10/12/2023 - 8 months ago
    40 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 10/14/2023 - 8 months ago
    41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/15/2024 - 2 months ago
    42 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/15/2024 - 2 months ago
    43 - SOU EXTENSION 5 FILED Type: EXT5
  • 4/15/2024 - 2 months ago
    44 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 4/16/2024 - 2 months ago
    45 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA